Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1997-2-4
pubmed:abstractText
1. The electrophysiological properties and beta-adrenergic regulation of a non-inactivating K+ current were studied using the whole-cell patch-clamp technique (22 +/- 2 degrees C) in adult rat ventricular cells. 2. In the presence of 4-aminopyridine, an inhibitor of the rapidly inactivating current, the depolarization-activated current consisted only of a slowly decaying outward current (IK). The presence of a non-inactivating current (ISS) was revealed when analysing inactivation curves. 3. IK and ISS were both sensitive to 50 mM tetraethylammonium and 10 mM 4-aminopyridine inhibition. IK was totally blocked by 100 microM clofilium, while ISS was not inhibited but rather enhanced by this class III anti-arrhythmic agent. 4. Unlike IK, ISS was only slightly decreased by depolarizing prepulses and it did not show time-dependent inactivation when measured during 500 ms depolarizations. 5. ISS was decreased by the beta-adrenergic agonist isoprenaline (1 microM). Forskolin (10 microM) mimicked the effects of isoprenaline. The non-specific beta-adrenergic antagonist, propranolol (3 microM), and a specific beta 1-adrenergic antagonist, CGP 20712A (0.3 microM), both prevented the effects of isoprenaline. Cell perfusion with 100 microM PKI6-22, a peptide inhibitor of the cyclic AMP-dependent protein kinase, reduced or abolished the effects of isoprenaline. 6. The dose-response curve for the inhibition of ISS by isoprenaline was positioned to the left of that for the calcium current. The threshold dose and the dose giving 50% of the maximal effect were, respectively, 0.1 and 0.21 nM for ISS and 1 and 4.3 nM for ICa. 7. In view of the high sensitivity of ISS to isoprenaline, its possible physiological effect was evaluated on action potential duration during beta-adrenergic stimulation. At 1 nM, a concentration that did not increase ICa, isoprenaline induced a significant prolongation of action potential duration as a consequence of ISS inhibition. With 1 microM isoprenaline, the action potential was further prolonged, due largely to an evoked increase in ICa. 8. In conclusion, a K+ current displaying a weak voltage-dependent inactivation is present in rat ventricular cells. It is inhibited by stimulation of beta 1-adrenergic receptors and is highly sensitive to phosphorylation by protein kinase A. This current may play an important role in the neuromodulation of excitation-contraction coupling.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-1655403, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-1661086, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-1705709, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-1715584, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-1770442, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-1865177, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-1973082, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-1973193, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-1984874, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2161457, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2170562, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2427246, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2446513, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2455861, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2471837, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2545864, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2561787, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2610249, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2640462, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2770868, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2845575, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2847114, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2903506, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-2916119, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-6270629, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-7510407, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-7971176, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8033339, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8139705, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8184933, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8222078, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8226976, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8262973, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8287238, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8287446, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8290574, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8413671, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8443875, http://linkedlifedata.com/resource/pubmed/commentcorrection/9011624-8510021
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/4-Aminopyridine, http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-1 Receptor Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-1 Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Arrhythmia Agents, http://linkedlifedata.com/resource/pubmed/chemical/Isoproterenol, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels, http://linkedlifedata.com/resource/pubmed/chemical/Quaternary Ammonium Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta, http://linkedlifedata.com/resource/pubmed/chemical/Tetraethylammonium Compounds, http://linkedlifedata.com/resource/pubmed/chemical/clofilium
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-3751
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
491 ( Pt 1)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
81-97
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:9011624-4-Aminopyridine, pubmed-meshheading:9011624-Adrenergic beta-1 Receptor Agonists, pubmed-meshheading:9011624-Adrenergic beta-1 Receptor Antagonists, pubmed-meshheading:9011624-Adrenergic beta-Agonists, pubmed-meshheading:9011624-Animals, pubmed-meshheading:9011624-Anti-Arrhythmia Agents, pubmed-meshheading:9011624-Electrophysiology, pubmed-meshheading:9011624-Heart Ventricles, pubmed-meshheading:9011624-Isoproterenol, pubmed-meshheading:9011624-Male, pubmed-meshheading:9011624-Membrane Potentials, pubmed-meshheading:9011624-Myocardium, pubmed-meshheading:9011624-Patch-Clamp Techniques, pubmed-meshheading:9011624-Potassium Channels, pubmed-meshheading:9011624-Quaternary Ammonium Compounds, pubmed-meshheading:9011624-Rats, pubmed-meshheading:9011624-Rats, Wistar, pubmed-meshheading:9011624-Receptors, Adrenergic, beta, pubmed-meshheading:9011624-Tetraethylammonium Compounds
pubmed:year
1996
pubmed:articleTitle
Characterization of a beta-adrenergically inhibited K+ current in rat cardiac ventricular cells.
pubmed:affiliation
Laboratoire de Physiopathologie Cardiovasculaire, INSERM U-390, Centre Hospitalier Universitaire Arnaud de Villeneuve, Montpellier, France.
pubmed:publicationType
Journal Article